Elon's Vision
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

HairLabs Launches Anti Grey 1.0 – World’s First AI-Powered Hair Supplement Designed to Protect Stem Cells

by
June 18, 2025
in Stock
0
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

London-based biotech firm HairLabs, known for its cutting-edge work in hair healthspan, has today unveiled Anti Grey 1.0 – a pioneering daily nutraceutical created to support the preservation of melanocyte stem cells (MSCs), the key to maintaining natural hair pigmentation. The product officially goes on sale from Friday 13 June 2025 at hairlabs.ai, with both one-off purchases and subscription…

Source

Previous Post

CMD Recruitment Warns Employers Risk Lagging Behind on Staff Benefits

Next Post

UK watchdog fines 23andMe for ‘profoundly damaging’ data breach

Next Post
UK watchdog fines 23andMe for ‘profoundly damaging’ data breach

UK watchdog fines 23andMe for ‘profoundly damaging’ data breach

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023
Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

January 31, 2025

An update on the National Nature Assessment

April 23, 2025
Trump’s War Insurance Decree Follows Predictable Pattern

Trump’s War Insurance Decree Follows Predictable Pattern

0

0

0

0
Trump’s War Insurance Decree Follows Predictable Pattern

Trump’s War Insurance Decree Follows Predictable Pattern

March 5, 2026
Americans Trust Their Doctors More Than Federal Health Agencies—Maybe It’s Time Public Health Policy Reflected That

Americans Trust Their Doctors More Than Federal Health Agencies—Maybe It’s Time Public Health Policy Reflected That

March 5, 2026

Trump’s Iran War Shows How American “Democracy” Really Works

March 5, 2026

The Duke Lacrosse Case Exposed the Rot in Higher Education, the Media, and the Justice System

March 5, 2026

Recent News

Trump’s War Insurance Decree Follows Predictable Pattern

Trump’s War Insurance Decree Follows Predictable Pattern

March 5, 2026
Americans Trust Their Doctors More Than Federal Health Agencies—Maybe It’s Time Public Health Policy Reflected That

Americans Trust Their Doctors More Than Federal Health Agencies—Maybe It’s Time Public Health Policy Reflected That

March 5, 2026

Trump’s Iran War Shows How American “Democracy” Really Works

March 5, 2026

The Duke Lacrosse Case Exposed the Rot in Higher Education, the Media, and the Justice System

March 5, 2026

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.